 number of 719 patients (CEAP C2-C5). Compared
with placebo, the RR for pain was 0.35 (P < .00,001),
for heaviness 0.26 (P < .00001), for sensation of
swelling 0.53 (P < .0001), for paresthesia 0.27 (P <
.0001), and for